| abstract |
The present invention relates to a pharmaceutical combination preparation comprising a platelet aggregation inhibitor and an HMG-CoA reductase inhibitor, and more particularly, to a platelet aggregation inhibitor or a pharmaceutically acceptable salt, acidity regulator and pharmaceutically acceptable additive thereof. An inner layer coated with an enteric core containing an inner core; An interlayer comprising a water soluble polymer; And an outer layer comprising an HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof, a water soluble polymer, and a pharmaceutically acceptable additive. |